Post-COVID-19 infections and evolution of pulmonary and cardiac lesions – the battle has just started

1. Ojo AS, Balogun SA, Williams OT, Ojo OS. Pulmonary fibrosis in COVID-19 survivors: Predictive factors and risk reduction strategies. Pulmonary Medicine. 2020;10. Available from: doi: 10.1155/2020/6175964.10.1155/2020/6175964743916032850151Search in Google Scholar

2. Hui DS, Joynt GM, Wong KT, Gomersall CD, Li TS, Antonio G. Impact of severe acute respiratory syndrome (SARS) on pulmonary function, functional capacity and quality of life in a cohort of survivors. Thorax. 2005;60(5): 401–409.10.1136/thx.2004.030205175890515860716Search in Google Scholar

3. NHS England. Aftercare needs of inpatients recovering from COVID-19. Jun 2020. Available from: https://www.england.nhs.uk/coronavirus/publication/after-care-needs-of-inpatients-recoveringfrom-covid-19.Search in Google Scholar

4. Zhang P, Li J, Liu H, Han N, Ju J, Kou Y, et al. Long-term bone and lung consequences associated with hospital-acquired severe acute respiratory syndrome: a 15-year follow-up from a prospective cohort study. Bone Research. 2020;8: 8.10.1038/s41413-020-0084-5701871732128276Search in Google Scholar

5. Chen J, Wu J, Hao S, Yang M, Lu X, Chen X, et al. Long term outcomes in survivors of epidemic influenza A (H7N9) virus infection. Scientific Reports. 2017;7: 17275.10.1038/s41598-017-17497-6572286129222500Search in Google Scholar

6. Zuo W, Zhao X, Chen YG. SARS Coronavirus and lung fibrosis. Molecular biology of the SARS-Coronavirus. 2009;247–258. Published 2009 Jul 22. Available from: doi: 10.1007/978-3-642-03683-5_15.10.1007/978-3-642-03683-5_15Search in Google Scholar

7. Ioshi A. Long term complications associated with Covid-19: a review. International Journal of Innovative Science and Research Technology 2020;5(9): 324–326.10.38124/IJISRT20SEP144Search in Google Scholar

8. TOI STAFF-(Akiko Iwasaki, a professor of immunobiology at Yale interview)- ‘Long COVID’ may be caused by body attacking itself, not the virus – study-14 December 2020, The Times from Israel.Search in Google Scholar

9. Potus F, Mai V, Lebret M, Malenfant S, Breton-Gagnon E, Lajoie AC. Novel insights on the pulmonary vascular consequences of COVID-19. American Journal of Physiology-Lung Cellular and Molecular Physiology. 2020;319(2): L277–L288.10.1152/ajplung.00195.2020741423732551862Search in Google Scholar

10. Geddes L. Why strange and debilitating coronavirus symptoms can last for months. Scientist 2020. Available from: https://www.newscientist.com/article/mg24632881-400-why-strange-and-debilitatingcoronavirus-symptoms-can-last-for-months/.Search in Google Scholar

11. Ding X, Xu J, Zhou J, Long Q. Chest CT findings of COVID-19 pneumonia by duration of symptoms. European Journal of Radiology. 2020;127: 109009. Available from: doi: 10.1016/j. ejrad.2020.10900 910.1016/j.ejrad.2020.109009Search in Google Scholar

12. COVID Symptom Study. How long does COVID-19 last? Kings College London; 2020. Available from https://covid19.joinzoe.com/post/covid-long-term?fbclid=IwAR1RxIcmmdL-EFjh_aI-.Search in Google Scholar

13. Tian S, Xiong Y, Liu H, Niu L, Guo J, Liao M, et al. Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies. Modern Pathology. 2020. Available from: doi: 10.1038/s41379-020-0536-x.10.1038/s41379-020-0536-x715623132291399Search in Google Scholar

14. Marchiori E, Hochhegger B, Zanetti G. Organising pneumonia as a late abnormality in influenza A (H1N1) virus infection. The British Journal of Radiology. 2012;85: 841; author reply 842.10.1259/bjr/91363092347412622665929Search in Google Scholar

15. Ong K-C, Ng AW-K, Lee LS-U, Kaw G, Kwek S-K, Leow MK-S, et al. 1-year pulmonary function and health status in survivors of severe acute respiratory syndrome. Chest. 2005;128: 1393–1400.10.1378/chest.128.3.1393709473916162734Search in Google Scholar

16. Kreuter M, Polke M, Walsh SL, Krisam J, Collard HR, Chaudhuri N, et al. Acute exacerbation of idiopathic pulmonary fibrosis: international survey and call for harmonization. European Respiratory Journal. 2020;55(4): 1901760.10.1183/13993003.01760-2019Search in Google Scholar

17. Cao Y, Liu X, Xiong L, Cai K. Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2: a systematic review and meta-analysis. Journal of Medical Virology. 2020. Available from: doi: 10.1002/jmv.25822.10.1002/jmv.25822Search in Google Scholar

18. Huang Y, Tan C, Wu J, Chen M, Wang Z, Luo L, et al. Impact of coronavirus disease 2019 on pulmonary function in early convalescence phase. Respiratory Research. 2020;21: 163. Available from: doi: 10.1186/s12931-020-01429-6.10.1186/s12931-020-01429-6Search in Google Scholar

19. Hui DS, Wong KT, Ko FW, Tam LS, Chan DP, Woo J, et al. The 1-year impact of severe acute respiratory syndrome on pulmonary function, exercise capacity, and quality of life in a cohort of survivors. Chest. 2005;128(4): 2247–2261.10.1378/chest.128.4.2247Search in Google Scholar

20. Zheng Z, Chen R, Wu H, Liu X, He W, Xu Y, et al. Changes in pulmonary function in severe acute respiratory syndrome patients during convalescent period. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2005;17(6): 329.Search in Google Scholar

21. NGAI JC, Ko FW, Ng SS, To K-W, Tong M, Hui DS. The long-term impact of severe acute respiratory syndrome on pulmonary function, exercise capacity and health status. Respirology. 2010;15(3): 543–550.10.1111/j.1440-1843.2010.01720.xSearch in Google Scholar

22. Zhao YM, Shang YM, Song WB, Li Q-Q, Xie H, Xu QF, et al. Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery. E ClinicalMedicine. 2020;25: 100463. Available from: doi: 10.1016/j.eclinm.2020.100463.10.1016/j.eclinm.2020.100463Search in Google Scholar

23. Ahmed H, Patel K, Greenwood D, Halpin St., Lewthwaite P, Salawu A, et al. Long-term clinical outcomes in survivors of coronavirus outbreaks after hospitalisation or ICU admission: a systematic review and meta-analysis of follow-up studies. medRxiv. 2020.04.16.20067975; Available from: doi: 10.1101/2020.04.16.20067975.10.1101/2020.04.16.20067975Search in Google Scholar

24. Cardinal-Fernández P, Lorente JA, Ballén-Barragán A, Matute-Bello G. Acute respiratory distress syndrome and diffuse alveolar damage. New insights on a complex relationship. Annals of the American Thoracic Society. 2017;14: 844–850.10.1513/AnnalsATS.201609-728PSSearch in Google Scholar

25. Kumar Rai D, Sharma P, Kumar R. Post covid 19 pulmonary fibrosis- Is it reversible? Indian Journal of Tuberculosis, 2020, Available from: doi: 10.1016/j.ijtb.2020.11.003. Available from: http://www.sciencedirect.com/science/article/pii/S0019570720302134.Search in Google Scholar

26. Spagnolo P, Balestro E, Aliberti S, Cocconcelli E, Biondini D, Casa GD, et al. Pulmonary fibrosis secondary to COVID-19: a call to arms? Lancet Respiratory Medicine. 2020;8(8): 750–752.10.1016/S2213-2600(20)30222-8Search in Google Scholar

27. Leung TYM, Chan AYL, Chan EW, Chan VKY, Chui CSL, Cowling BJ, et al. Short- and potential long-term adverse health outcomes of COVID-19: a rapid review. Emerging Microbes & Infections. 2020;9(1): 2190–2199.10.1080/22221751.2020.1825914758644632940572Search in Google Scholar

28. Carfì A, Bernabei R, Landi F, for the Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6): 603–605.10.1001/jama.2020.12603734909632644129Search in Google Scholar

29. Tenforde MW, Kim SS, Lindsell CJ, Rose EB., Shapiro NI, Files DC, et al. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network — United States, March–June 2020. Morbidity and Mortality Weekly Report. 2020;69: 993–998.10.15585/mmwr.mm6930e1739239332730238Search in Google Scholar

30. Lam MH-B, Wing Y-K, Yu MW-M, Leung C-M, Ma RCW, Kong APS, et al. Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: long-term Follow-up. Archives of Internal Medicine. 2009;169(22): 2142–2147.10.1001/archinternmed.2009.38420008700Search in Google Scholar

31. Dhama K, Khan S, Tiwari R, Sircar S, Bhat S, Malik YS, et al. Rodriguez-Morales Coronavirus Disease 2019–COVID-19. Available from: doi: 10.1128/CMR.00028-20.10.1128/CMR.00028-20740583632580969Search in Google Scholar

32. Fraser E. Long term respiratory complications of covid-19. BMJ. 2020;370: m3001. Available from: doi: 10.1136/bmj.m3001 (Published 03 August 2020.10.1136/bmj.m300132747332Search in Google Scholar

33. Assaf G, Davis H, McCorkell L, Wei H, Brooke O, Akrami A, et al. An analysis of the prolonged COVID-19 symptoms survey by Patient-Led Research Team. Patient Led Research, 2020. Available from: https://patientresearchcovid19.com/.Search in Google Scholar

34. Larun L, Brurberg KG, Odgaard-Jensen J, Price JR. Exercise therapy for chronic fatigue syndrome. Cochrane Database of Systematic Reviews. 2017;4: PMID: 28444695.10.1002/14651858.CD003200.pub7641952428444695Search in Google Scholar

35. Trisha G, Matthew K, Christine A’C, Maria B, Laiba H. Management of post-acute covid-19 in primary care. BMJ. 2020;370: m3026.10.1136/bmj.m302632784198Search in Google Scholar

36. Homerton University Hospital. Post COVID-19 patient information pack. 2020. Available from: https://www.hackneycitizen.co.uk/wp-content/uploads/Post-COVID-19-information-pack5.pdf.Search in Google Scholar

37. O’Driscoll BR, Howard LS, Earis J, Mak V; British Thoracic Society Emergency Oxygen Guideline Group; BTS Emergency Oxygen Guideline Development Group. BTS guideline for oxygen use in adults in healthcare and emergency settings. Thorax. 2017;72(Suppl 1): ii1-90.10.1136/thoraxjnl-2016-20972928507176Search in Google Scholar

38. National Institute for Health and Care Excellence. Statement about graded exercise therapy in the context of COVID-19. In: Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management (in development GID-NG10091). 2020. Available from: http://www.nice.org.uk/guidance/gid-ng10091/documents/statement.Search in Google Scholar

39. Hoffman GJ, Webster NJ, Bynum JPW. A framework for aging-friendly services and supports in the age of COVID-19. Journal of Aging & Social Policy. 2020;32: 450–459.10.1080/08959420.2020.177123932441572Search in Google Scholar

40. Mitrani RD, Dabas N, Goldberger JJ. COVID-19 cardiac injury: implications for long-term surveillance and outcomes in survivors. 2020;17(11): 1984–1990. Available from: doi: 10.1016/J. HRTHM.2020.06.0 26.Search in Google Scholar

41. Oudit GY, Kassiri Z, Jiang C, Liu PP, Poutanen SM, Penninger JM, et al. SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS. European Journal of Clinical Investigation. 2009;39(7): 618–625. Available from: doi: 10.1111/j.1365-2362.2009.02153.x.10.1111/j.1365-2362.2009.02153.x716376619453650Search in Google Scholar

42. Puntmann VO, Carerj ML, Wieters I, Fahim M, Arendt C, Hoffmann J, et al. Outcomes of cardiovascular magnetic resonance imaging (MRI) in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA Cardiology. 2020;5(11): 1265–1273.10.1001/jamacardio.2020.3557Search in Google Scholar

43. Yancy CW, Fonarow GC. Coronavirus disease 2019 (COVID-19) and the heart – is heart failure the next chapter? JAMA Cardiology. 2020;5(11): 1216–1217.10.1001/jamacardio.2020.3575Search in Google Scholar

44. Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiology. 2020;5(7): 811–818.10.1001/jamacardio.2020.1017Search in Google Scholar

45. Chang J-J, Lin M-S, Chen T-H, Chen D-Y, Chen S-W, Hsu J-T, et al. Heart failure and mortality of adult survivors from acute myocarditis requiring intensive care treatment – a Nationwide Cohort Study. International Journal of Medical Sciences. 2017;14: 1241–1250.10.7150/ijms.20618Search in Google Scholar

46. Mitrani RD, Abas N, Goldberger JJ. COVID-19 cardiac injury: Implications for long-term surveillance and outcomes in survivors. Heart Rhythm. 2020;17: 1984–1990.10.1016/j.hrthm.2020.06.026Search in Google Scholar

47. Andrejak C, Cottin V, Crestani B, Debieuvre D, Bermejo J-G, Panzini CM, et al. Guide de prise en charge des séquelles respiratoires post infection à SARS-CoV-2. Propositions de prise en charge élaborées par la Société de Pneumologie de Langue Francaise. Version du 10 novembre 2020. Revue des Maladies Respiratoires. 2020, Available from: doi: 10.1016/j. rmr.2020.11.009.10.1016/j.rmr.2020.11.009Search in Google Scholar

48. Horby P, Lim WS, Emberson J, Mafham M, Bell J, Linsell L, et al. Effect of dexamethasone in hospitalized patients with covid-19: preliminary report. MedRxiv 20202020.2006.2022.20137273 [Preprint]. Available from: https://www.medrxiv.org/content/10.1101/2020.06.22.20137273v1.Search in Google Scholar

49. George PM, Wells AU, Jenkins RG. Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy. The Lancet Respiratory Medicine. 2020;8(8): P507–P515. Available from: doi: 10.1016/S2213-2600(20)30225-3.10.1016/S2213-2600(20)30225-3Search in Google Scholar

50. British Thoracic Society. Guidance on respiratory follow up of patients with a clinico-radiological diagnosis of covid-19 pneumonia. 2020. Available from: www.brit-thoracic.org.uk.Search in Google Scholar

51. del Rio C, Collins LF, Malani P. Long-term Health Consequences of COVID-19. JAMA. 2020;324(17): 1723–1724.10.1001/jama.2020.19719Search in Google Scholar

52. Yelin D, Wirtheim E, Vetter P, Kalil AC, Bruchfeld J, Runold M, et al. Long-term consequences of COVID-19: research needs. Lancet Infectious Diseases. 2020;20(10): 1115–1117.10.1016/S1473-3099(20)30701-5Search in Google Scholar